NCT00410956 2024-12-10
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
7 trialsNCT00513461 2018-08-10
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
Phase 2 Completed
NCT01191684 2017-08-01
Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer
City of Hope Medical Center
Phase 1 Completed
NCT00897754 2017-05-19
Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab
Eastern Cooperative Oncology Group
Completed
NCT00550628 2015-12-23
Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
Memorial Sloan Kettering Cancer Center
Completed
NCT00900432 2015-12-03
Immune Response in Peripheral Blood of Patients With Colon Cancer
University of Arizona
Completed
NCT00471484 2011-06-22
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown